Search
Selected: All

Use of L-Carnitine as stabilizing agent of proteins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of lactoferrin for therapy of acute of chronic infectious di

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of lactoferrin for treatment of toxic effects of endotoxins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of lactoferrin to modulate and/or neutralize heparin activit

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of lecithin-cholesterol acyltransferase (LCAT) to reduce...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of leptin for treating human lipoatrophy and method of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of leukemia inhibitory factor and endothelin antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of leukemia inhibitory factor and endothelin antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of LH in controlled ovarian hyperstimulation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of lipopolysaccharides to manage corneal infections and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of low molecular weight thrombin inhibitor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of lupin conglutin for the treatment of type II diabetes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of MCP-1 for inducing ripening of the cervix

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of melagatran

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of melagatran for the manufacture of a medicament for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of melanin for inhibition of angiogenesis and macular...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of MHC class II ligands as adjuvant for vaccination and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of microparticles having a protein and an antibody...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of modified cyclosporins for the treatment of HCV disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of modified lysozyme C to prepare medicinal compositions...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.